Base de dados : LILACS
Pesquisa : C12.777.829.495 [Categoria DeCS]
Referências encontradas : 210 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 21 ir para página                         

  1 / 210 LILACS  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-975562
Autor: Castrillón Spitia, Juan Daniel; Machado-Alba, Jorge Enrique; Gómez Idarraga, Stefania; Gómez Gutierrez, Manuela; Remolina León, Natalia; Ríos Gallego, Juan José.
Título: Etiología y perfil de resistencia antimicrobiana en pacientes con infección urinaria / Etiology and antimicrobial resistance profile in patients with urinary infection
Fonte: Infectio;23(1):45-51, Jan.-Mar. 2019. tab.
Idioma: es.
Resumo: Resumen Introducción: La infección de vías urinarias (IVU) es una de las enfermedades más prevalentes en la práctica clínica Objetivo: Identificar los principales agentes etiológicos y la frecuencia de resistencia a antibióticos por parte de microorganismos aislados por urocultivos en pa cientes con IVU en un hospital de primer nivel de atención. Materiales y Métodos: Estudio descriptivo de corte transversal, a partir de una muestra aleatoria de pacientes con IVU en La Virginia, Risaralda, entre el 1 de abril de 2014 a 31 de marzo de 2015. Se evaluaron las bacterias aisladas en la totalidad de urocultivos procesados y los resultados de los antibiogramas. Se establecieron frecuencias y proporciones. Para el análisis de datos, se utilizó SPSS Statistics 22. Se hizo análisis multivariado. Resultados: Se realizaron 1563 urocultivos en el periodo de estudio, de los cuales 329 (21,0%) mostraron crecimiento mayor a 100.000 UFC. Las frecuencias más altas de resistencia para E. coli se observaron para cefalotina (75,8%), ampicilina (72,6%) y trimetoprim/sulfametoxazol (55,3%). De 296 pacientes seleccionados aleatoriamente se halló que la cistitis era la IVU más frecuente (70,3%) y al 50,7% no se les prescribió ningún antimicrobiano. El uso de antiulcerosos se asoció con mayor probabilidad de uso inadecuado del antibiótico (OR:4,28; IC95%:1,070-17,153; p=0,04). Conclusiones: Existe una elevada resistencia bacteriana a los antibióticos de primera línea para el tratamiento de las IVUs, lo que sugiere la importancia de identi ficar los microorganismos y sus perfiles de sensibilidad a antimicrobianos para seleccionar con mejor criterio cual emplear.

Abstract Introduction: Urinary tract infection (UTI) is one of the most prevalent diseases in clinical practice. Objective: To identify the main etiologic agents and the frequency of antibiotic resistance by microorganisms isolated from urine culture and sensitivity in patients with IVU in a hospital primary care. Materials and Methods. Descriptive cross-sectional study, from a random sample of patients with UTI in La Virginia, Risaralda, from April 1, 2014 to March 31, 2015. Bacteria isolated from all processed urine cultures and the results of susceptibility were evaluated. Frequencies and proportions were established. For data analysis was used SPSS Statistics 22. Results: A total of 1563 urine cultures were performed in the study period, of which 329 (21.0%) showed further growth to 100,000 UFC. Higher frequencies of resis tance were observed for E. coli to cephalothin (75.8%), ampicillin (72.6%) and trimethoprim/sulfamethoxazole (55.3%). In the 296 randomized patients it was found that the most common UTI was cystitis (70.3%) and 50.7% were not prescribed any antimicrobial. The use of anti-ulcer is associated with increased probability of inappropriate use of antibiotics (OR:4.28; 95% CI:1.070-17.153; p=0.04). Conclusions: There is a high bacterial resistance to first-line antibiotics for treatment of UTIs, suggesting the importance of identifying microorganisms and their antimicrobial susceptibility profiles to select which use better approach.
Descritores: Sistema Urinário
Infecções Urinárias
Resistência Microbiana a Medicamentos
Cefalosporinas
Cistite
Antibacterianos
-Sulfametoxazol
Bactérias
Trimetoprima
Cefalotina
Estudos Transversais
Análise Multivariada
Selectinas
Escherichia coli
Ampicilina
Anti-Infecciosos
Antiulcerosos
Limites: Humanos
Feminino
Adulto
Pessoa de Meia-Idade
Responsável: CO359.1 - ACIN - Asociación Colombiana de Infectologia


  2 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: lil-497165
Autor: Ibáñez, J; Garcia Chervo, L; Balbarrey, Z; Sarquis, C.
Título: Cistitis por polioma virus en paciente trasplantado renal / Palyoma virus cystitis in a child after a renal transplantation
Fonte: Med. infant;14(4):309-312, dic. 2007.
Idioma: es.
Descritores: Insuficiência Renal
Cistite
Polyomavirus
Transplante de Rim/efeitos adversos
Viremia/terapia
Limites: Criança
Tipo de Publ: Relatos de Casos
Responsável: AR94.1 - Centro de Información Pediatrica


  3 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-828944
Autor: Westerman, Mary E; Boorjian, Stephen A; Linder, Brian J.
Título: Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation
Fonte: Int. braz. j. urol;42(6):1144-1149, Nov.-Dec. 2016. tab.
Idioma: en.
Resumo: ABSTRACT Introduction: Hemorrhagic cystitis (HC) represents a challenging clinical entity. While various intravesical agents have been utilized in this setting, limited data exist regarding safety or efficacy. Herein, then, we evaluated the effectiveness and complications associated with intravesical alum instillation for HC in a contemporary cohort. Materials and Methods: We identified 40 patients treated with intravesical alum for HC between 1997-2014. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after alum instillation. Results: Median patient age was 76.5 years (IQR 69, 83). Pelvic radiation was the most common etiology for HC (n=38, 95%). Alum use decreased patient's transfusion requirement, with 82% (32/39) receiving a transfusion within 30 days before alum instillation (median 4 units) versus 59% (23/39) within 30 days after completing alum (median 3 units) (p=0.05). In total, 24 patients (60%) required no additional therapy prior to hospital discharge. Moreover, at a median follow-up of 17 months (IQR 5, 38.5), 13 patients (32.5%) remained without additional treatment for HC. Adverse effects were reported in 15 patients (38%), with bladder spasms representing the most common event (14/40; 35%). No clinical evidence of clinically significant systemic absorption was detected. Conclusion: Intravesical alum therapy is well-tolerated, with resolution of HC in approximately 60% of patients, and a durable response in approximately one-third. Given its favorable safety/efficacy profile, intravesical alum may be considered as a first-line treatment option for patients with HC.
Descritores: Cistite/tratamento farmacológico
Compostos de Alúmen/administração & dosagem
Hemorragia/tratamento farmacológico
-Administração Intravesical
Estudos Retrospectivos
Estudos de Coortes
Resultado do Tratamento
Cistite/complicações
Compostos de Alúmen/efeitos adversos
Alumínio/sangue
Hemorragia/etiologia
Irrigação Terapêutica
Limites: Masculino
Feminino
Idoso
Responsável: BR1.1 - BIREME


  4 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-892930
Autor: Yang, Zhenyu; Sheng, Chang.
Título: Gas surrounding the urinary bladder in emphysematous cystitis
Fonte: Int. braz. j. urol;43(6):1190-1191, Nov.-Dec. 2017. graf.
Idioma: en.
Resumo: ABSTRACT We report a rare case of emphysematous cystitis in a 66-year-old woman with a history of diabetes mellitus. The predisposition of diabetes mellitus and infection of gas-forming bacteria is considered to precede the manifestation of emphysematous cystitis. The present recommended diagnosis test is computed tomography, which have definite value in the evaluation of gas accumulation in bladder wall, or an air-fluid level in bladder.
Descritores: Cistite/diagnóstico por imagem
Enfisema/diagnóstico por imagem
-Tomografia Computadorizada por Raios X
Cistite/etiologia
Enfisema/etiologia
Limites: Humanos
Feminino
Idoso
Responsável: BR1.1 - BIREME


  5 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-840847
Autor: Dellis, Athanasios; Papatsoris, Athanasios; Kalentzos, Vasileios; Deliveliotis, Charalambos; Skolarikos, Andreas.
Título: Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis
Fonte: Int. braz. j. urol;43(3):489-495, May.-June 2017. tab.
Idioma: en.
Resumo: ABSTRACT Purpose To examine the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis. Materials and methods Hyperbaric oxygen was prospectively applied as primary treatment in 38 patients with severe radiation cystitis. Our primary endpoint was the incidence of complete and partial response to treatment, while the secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival. Results All patients completed therapy without complications with a mean follow-up of 29.33 months. Median number of sessions needed was 33. Complete and partial response rate was 86.8% and 13.2%, respectively. All 33 patients with complete response received therapy within 6 months of the haematuria onset. One patient needed cystectomy, while 33 patients were alive at the end of follow-up. Conclusions Our study suggests the early primary use of hyperbaric oxygen for radiation-induced severe cystitis as an effective and safe treatment option.
Descritores: Lesões por Radiação
Cistite/terapia
Oxigenação Hiperbárica/métodos
-Lesões por Radiação/complicações
Índice de Gravidade de Doença
Cistectomia
Estudos Prospectivos
Resultado do Tratamento
Cistite/etiologia
Pessoa de Meia-Idade
Limites: Humanos
Masculino
Feminino
Idoso
Idoso de 80 Anos ou mais
Responsável: BR1.1 - BIREME


  6 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-975670
Autor: Ozkan, Tayyar Alp; Yalcin, Mustafa Savas; Dillioglugil, Ozdal; Cevik, Ibrahim.
Título: Encrusted cystitis caused by corynebacterium urealyticum: a case report with novel treatment strategy of intravesical dimethyl sulfoxide
Fonte: Int. braz. j. urol;44(6):1252-1255, Nov.-Dec. 2018. graf.
Idioma: en.
Resumo: ABSTRACT Encrusted cystitis (EC) was first described as chronic cystitis with mucosal calcification in 1914 (1). It is a very rare chronic inflammatory disease presenting with dysuria, pelvic pain and gross hematuria. Voided urine contains mucus or calcified mucopurulent stone like particles. Urinalysis always reveals alkaline pH. It may be present in healthy individuals with no predisposing etiological factors (2-4). Etiologically, previous urological diseases, immunosuppression, urinary infection with urea splitting bacteria, or urological interventions resulting in bladder mucosa trauma may also be present (5, 6). In the present case report, we describe a novel treatment for EC with intravesical dimethyl sulfoxide.
Descritores: Dimetil Sulfóxido/uso terapêutico
Corynebacterium/classificação
Infecções por Corynebacterium/tratamento farmacológico
Cistite/tratamento farmacológico
-Administração Intravesical
Doença Crônica
Resultado do Tratamento
Corynebacterium/isolamento & purificação
Infecções por Corynebacterium/diagnóstico
Infecções por Corynebacterium/microbiologia
Cistite/diagnóstico
Cistite/microbiologia
Limites: Humanos
Masculino
Adulto
Tipo de Publ: Relatos de Casos
Responsável: BR1.1 - BIREME


  7 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-954053
Autor: Chen, Yu-Chen; Chen, Hao-Wei; Juan, Yung-Shun; Wu, Wen-Jeng; Tsai, Chia-Chun.
Título: Re: Gaseous bladder tamponade secondary to emphysematous cystitis
Fonte: Int. braz. j. urol;44(3):653-654, May-June 2018. graf.
Idioma: en.
Descritores: Cistite
Tipo de Publ: Comentário
Carta
Responsável: BR1.1 - BIREME


  8 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1144382
Autor: Torres Serrano, Rodolfo; Dueñas, Alejandro; Lamos, Andrés; Rodríguez, Cristian; Hincapié, Daniela Trujillo.
Título: Cistitis enfisematosa. Reporte de un caso / Emphysematous cistitis. A case report
Fonte: Rev. colomb. nefrol. (En línea);7(1):143-148, ene.-jun. 2020. tab, graf.
Idioma: es.
Resumo: Resumen La cistitis enfisematosa hace referencia a una entidad infrecuente, generalmente secundaria a infecciones de vías urinarias bajas, que por diferentes mecanismos producen gas alrededor de la vejiga. Esta patología se asocia a gérmenes (E. Coli, Enterobacter Arogenes, y Klebsiella, entre otros), y factores de riesgo como género femenino, edad avanzada y diabetes. Este diagnóstico requiere un manejo oportuno, con antibioticoterapia dirigida y control de comorbilidades asociadas; a continuación, se reporta el caso de un paciente masculino de 81 años, en el hospital de San José de Bogotá, a quien se le diagnostica esta patología, con el respectivo aislamiento microbiológico, factores de riesgo, diagnóstico y manejo instaurado.

Abstract The emphysematous cystitis refers to an uncommon entity generally secondary to low urinary tract infections producing gas around the bladder. It is associated with infections by E. Coli, Enterobacter Arogenes, and Klebsiella as well as patient risk factors such as advanced age, diabetics and female gender. The diagnosis requires a timely management as well as directed antibiotic and associated comorbidities control. In the following case report a male patient is described in the hospital of San José de Bogotá in whom this pathology is diagnosed. In the following case report we going to describe etiologies diagnosis and therapy.
Descritores: Cistite
-Pacientes
Infecções Urinárias
Relatos de Casos
Fatores de Risco
Colômbia
Diabetes Mellitus Tipo 2
Limites: Humanos
Masculino
Idoso de 80 Anos ou mais
Tipo de Publ: Relatos de Casos
Responsável: CO661.9


  9 / 210 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-1154442
Autor: Mattos, Ricardo Castellani de; Guimarães, Isabella dos Santos; Thiago, Leandro de Souza; Melo, Andreia Cristina de.
Título: Evaluation of HIF-1α and VEGF-A expression in radiation-induced cystitis: A case-control study
Fonte: Int. braz. j. urol;47(2):295-305, Mar.-Apr. 2021. tab, graf.
Idioma: en.
Resumo: ABSTRACT The standard treatment for locally advanced cervical cancer (CC) is chemoradiotherapy. Once the bladder receives part of the radiation, a typical inflammatory condition that configures radiation-induced cystitis may develop. Chronic radiation-induced cystitis is commonly characterized by the bladder new submucosal vascularization, which is typically fragile and favors hematuria. The current study aims to investigate if Hypoxia-Induced Factor (HIF-1α) and its transcriptional target Vascular Endothelial Growth Factor A (VEGF-A) could be a primary pathway leading to increased submucosal vascularization. HIF-1α and VEGF-A mRNA levels in bladder core biopsies from CC patients treated with radiotherapy versus untreated (non-irradiated) patients were analyzed using a droplet digital polymerase chain reaction technology. Gene expression results showed that HIF-1α and VEGF-A had no significant differences between bladder samples from patients previously irradiated and untreated patient samples. However, a direct relationship between the degree of late morbidity and the expression of HIF-1α and VEGF-A has been demonstrated. Despite the lack of statistical significance precludes a definitive conclusion, the data presented herein suggests that further studies investigating the role of HIF-1α in bladder neovascularization in radiation-induced cystitis are highly recommended.
Descritores: Neoplasias do Colo do Útero
Cistite/etiologia
-Estudos de Casos e Controles
Fator A de Crescimento do Endotélio Vascular
Subunidade alfa do Fator 1 Induzível por Hipóxia/genética
Neovascularização Patológica
Limites: Humanos
Feminino
Responsável: BR1.1 - BIREME


  10 / 210 LILACS  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-1154479
Autor: Reis, Rodolfo Borges dos; Rodrigues Junior, Antonio Antunes; Feres, Rafael Neuppmann; Muglia, Valdair Francisco.
Título: Editorial Comment: Evaluation of HIF-1α and VEGF-A expression in radiation-induced cystitis: A case-control study
Fonte: Int. braz. j. urol;47(2):306-307, Mar.-Apr. 2021.
Idioma: en.
Descritores: Cistite/etiologia
Fator A de Crescimento do Endotélio Vascular
-Estudos de Casos e Controles
Subunidade alfa do Fator 1 Induzível por Hipóxia
Limites: Humanos
Tipo de Publ: Comentário
Editorial
Responsável: BR1.1 - BIREME



página 1 de 21 ir para página                         
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde